IU Northwest taps Purdue-North Central dean to lead its School of Business and Economics

Posted on June 24th, 2016 | By Bill W. Hornaday

Screen Shot 2016-06-23 at 3.25.27 PM

Cynthia Roberts, who served in numerous administrative roles at Purdue University’s North Central campus in Westville for the past 16 years, will become dean of Indiana University Northwest’s School of Business and Economics effective Aug. 1.

Cynthia Roberts_resized

Cynthia Roberts

During her tenure at Purdue-North Central, Roberts chaired its Department of Business and Leadership, directed its MBA program and served as the Teddy Jacobi Dean of its College of Business.

“IU Northwest, and in particular, the School of Business and Economics, has enjoyed a long history in our region of academic excellence,” Roberts said. “I look forward to working with my new colleagues to explore opportunities to make an even greater impact on the lives of our students as well as the social and economic well-being of the region.”

Roberts earned her Ph.D. in organization development from Benedictine University in Lisle, Ill. and two master’s degrees from Loyola University in Chicago.

Read more about Roberts’ appointment here.

Dr. Anantha Shekhar – recipient of the first IURTC Outstanding Innovator Award

Posted on June 23rd, 2016 | By Steve Martin
Anantha Shekhar, left, receives the IURTC Outstanding Innovator Award from IU President and IURTC Chairman Michael A. McRobbie.

Anantha Shekhar, left, receives the IURTC Outstanding Innovator Award from IU President and IURTC Chairman Michael A. McRobbie.

Congratulations to Dr. Anantha Shekhar on receiving the first IURTC Outstanding Innovator Award. He was recognized at the June 22 meeting of the IURTC Board of Trustees.

Shekhar is the August M. Watanabe Professor of Medical Research and a professor of psychiatry, neurobiology and pharmacology in the Indiana University School of Medicine and co-founder of Anagin LLC. He will also lead the Precision Health Initiative, the first recipient of funding under the university’s new $300 million Grand Challenges Program.

More information, including quotes from Shekhar, IU President Michael A. McRobbie and IURTC President and CEO Tony Armstrong, is available here.

IU-developed cells licensed to Canadian firm

Posted on June 21st, 2016 | By Steve Martin

iurtc-logo2

 

Indiana University Research and Technology Corp., which protects, markets and licenses intellectual property developed at Indiana University so it can be commercialized by industry, has licensed cells developed at IU to Applied Biological Materials Inc., a life science company based in Richmond, British Columbia, Canada.

The Kupffer cells are mouse liver cells that can be grown in vitro. They also are able to undergo division for long periods of time, which means researchers studying liver function can use genetically identical cells in repeatable experiments.

Researchers from the Indiana University School of Medicine and Indiana University School of Public Health-Bloomington developed the cells. More information about the licensing agreement is available here.

Initiative aimed at producing patient-centered medicinal therapies wins first round of $300 million Grand Challenges research funding

Posted on June 21st, 2016 | By Bill W. Hornaday

ClZ4kx9UYAAPT5U

The Precision Health Initiative, a broad-reaching proposal to develop patient-centered medicinal therapies, was announced Monday as the first funding recipient of Indiana University’s $300 million Grand Challenges Program.

Led by Associate Vice President for Clinical Affairs and IU School of Medicine Executive Associate Dean for Research Affairs Anantha Shekhar, the initiative will seek to cure at least one cancer and one childhood disease, as well as explore ways to prevent one chronic illness and one neurodegenerative disease.

The initiative includes faculty at the IU School of Medicine, IU Bloomington and Indiana University-Purdue University Indianapolis, with team members working closely with business and industry partners such as Eli Lilly and Co., Roche Diagnostics, Cook Regentec, Deloitte, Regenstrief Institute and IU Health.

“Precision health and person-centered approaches to patient care will be the next paradigm shift for health care delivery, and likely the dominant new forces in training the next generation of graduates from health sciences schools,” said Shekhar, who is also co-founder of Anagin LLC, a company that seeks to treat post-traumatic stress disorder without producing harmful side effects, as well as traumatic brain injuries.

“The goal of precision medicine is to get the right prevention or treatment to the right patient at the right time, and this initiative will enable us to do that for Hoosiers across the state.”

The Grand Challenges program is the most ambitious research effort in IU’s 196-year history. Over five years, the program will invest up to $300 million to address some of the most urgent challenges facing Indiana and the world.

The Precision Health Initiative was among five finalist teams selected from 21 proposals from IU faculty members representing 29 schools on six IU campuses statewide. The initiative will receive up to $40 million in Grand Challenges funding, plus up to $80 million from the IU School of Medicine. The team expects to hire about 40 new, full-time faculty members, including at least 22 at the IU School of Medicine, 15 at IU Bloomington and two at IUPUI.

Read more about Monday’s announcement here.